Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors

导出原文传递

翻译打印收藏纠错

作者： Pryce,G. ^[1] ; Cabranes,A. ^[2] ; Fernández-Ruiz,J. ^[3] ; Bisogno,T. ^[4] ; DiMarzo,V. ^[5] ; Long,J.Z. ^[6] ; Cravatt,B.F. ; Giovannoni,G. ; Baker,D.

作者单位： Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of ^[1] Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Italy, Department of ^[2] Department of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University ^[3] Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Italy ^[4] Skaggs Institute for Chemical Biology, Scripps Research Institute, United States ^[5] Department of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University, Spain ^[6]

关键词 Anandamide endocannabinoid experimental autoimmune encephalomyelitis fatty acid amide hydrolase multiple sclerosis spasticity

发布时间 2014-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交